Results 81 to 90 of about 2,228 (187)

Clinical Characteristics, Treatment Patterns, and Outcomes of Chinese Patients With Alopecia Areata: A Retrospective Observational Study

Journal of Cosmetic Dermatology, Volume 25, Issue 7, July 2026.
ABSTRACT Background Alopecia areata (AA) is an inflammatory, nonscarring hair loss disorder with significant variations in the clinical presentation and unpredictable nature of the disease. Although AA is common in clinical dermatology, knowledge gaps remain regarding the clinical characteristics and impact on patients' psychological well‐being and ...
Youyu Sheng, Zhibing Qiu, Jun Zhao, Lijuan Zhou, Ying Miao, Bilian Zhao, Jinnan Li, Guanshen Dou, Wenyu Wu, Qinping Yang   +9 more
wiley   +1 more source

Do Alopecia Areata and Hair Colour Have a Shared Genetic Component?

Experimental Dermatology, Volume 35, Issue 6, June 2026.
The aim of our study was to determine whether hair colour and the risk of developing alopecia areata (AA) share a genetic basis. While we found no evidence for a broadly shared polygenic background, our analyses revealed suggestive evidence that genetically predicted blond hair is associated with a reduced risk of AA. ABSTRACT Alopecia areata (AA) is a
Leonie Rieger‐Molitor, Carlo Maj, Silke Redler, Yasmina Gossmann, Stephan Ripke, Lynn Pethukova, Angela M. Christiano, Markus M. Nöthen, F. Buket Basmanav, Regina C. Betz   +9 more
wiley   +1 more source

Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis [PDF]

, 2003
Background: Efficacy of topical steroids in alopecia areata is still discussed. Objective: The purpose of this study was to evaluate the efficacy of clobetasol propionate 0.05% ointment under occlusion in 28 patients with alopecia areata totalis (AT) or ...
Tosti A., Vincenzi C., Piraccini B. M., Pazzaglia M.   +3 more
core   +1 more source

Alopecia Universalis following Alemtuzumab Treatment in Multiple Sclerosis: A Barely Recognized Manifestation of Secondary Autoimmunity—Report of a Case and Review of the Literature

Frontiers in Neurology, 2017
Secondary autoimmunity is the most frequent adverse event occurring in almost every other alemtuzumab-treated multiple sclerosis patient. We report a case of a patient with relapsing-remitting multiple sclerosis who reported smooth, circular areas of ...
Julian Zimmermann, Timo Buhl, Marcus Müller   +2 more
doaj   +1 more source

Alopecia Risk With GLP‐1 Receptor Agonists: A Disproportionality Analysis Using the FDA Adverse Event Reporting System (FAERS)

Journal of Cosmetic Dermatology, Volume 25, Issue 6, June 2026.
ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1‐RAs), a class of drugs indicated for diabetes mellitus and weight control, have been implicated in alopecia. We mined data from the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) to better understand the relationship between alopecia and GLP‐1‐RAs.
Aditya K. Gupta, Elizabeth Teasell, Mary A. Bamimore, Paradi Mirmirani, Mesbah Talukder   +4 more
wiley   +1 more source

P01-238 - Alopecia universalis causes serious personality derangements: first report of negative impact of a medical condition on personality (279 patients) [PDF]

, 2010
ObjectiveTo evaluate the reason of major behavioral problems in patients with alopecia universalis, we tried to examine by way of the Millon's MCMI- III whether these signs are transient or ingrained.MethodsPatients with alopecia universalis (279 ...
K. Pirkalani
core   +1 more source

Co‐Occurrence of Agminated Lentigines, Café‐Au‐Lait Macules, and Vitiligo: A Case Report and Literature Review

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Lentigines, café‐au‐lait macules (CALMs), and vitiligo are pigmentary disorders that seldom occur together in a single individual. Their co‐occurrence may indicate underlying genetic syndromes requiring differential diagnosis. We report an 18‐year‐old male who developed CALMs at age 11, agminated lentigines at age 13, and vitiligo on the right
Xinxin Lei, Bo Xie
wiley   +1 more source

Gastrointestinal strictures in a pediatric patient with Satoyoshi syndrome

JPGN Reports, Volume 7, Issue 2, Page 247-251, May 2026.
Abstract We present a novel case of gastrointestinal strictures in a young girl with Satoyoshi syndrome (SS), highlighting multi‐system features of alopecia universalis, painful muscle cramps with dystonia, aberrant growth velocity, and skeletal abnormalities.
Katherine (Tusia) Pohoreski, Gary Galante, Kiera Pajunen, Marie‐Anne Brundler, Samarjeet Bhandal, Iwona Wrobel   +5 more
wiley   +1 more source

The Genetic Basis of Alopecia Areata: HLA Associations with Patchy Alopecia Areata Versus Alopecia Totalis and Alopecia Universalis [PDF]

, 1999
Many diseases, notably those having a strong autoimmune component, have been shown to have an association with specific human leukocyte antigens (HLA).
Lou, Calvin D., Colombe, Beth W., Price, Vera H.   +2 more
core   +1 more source

Real‐World Outcomes of Baricitinib and Ritlecitinib in Refractory Alopecia Areata: Response Predictors and Relapse After Discontinuation or Dose Reduction

The Journal of Dermatology, Volume 53, Issue 5, Page 746-757, May 2026.
ABSTRACT Baricitinib and ritlecitinib are newly approved systemic Janus kinase (JAK) inhibitors for severe, refractory alopecia areata (AA). Although clinical trials have demonstrated their efficacy, real‐world evidence remains limited, particularly regarding predictors of response and outcomes following treatment interruption or dose tapering.
Rina Hayashi, Saori Takamura, Tomoo Fukuda   +2 more
wiley   +1 more source